The hot flashes got all the attention, but it was the blood pressure creep and that strange new coldness in my hands and feet that really unsettled me. Nobody connected it to estrogen or nitric oxide — it just got filed under 'getting older.' Learning that there's actual physiology behind those changes, and that researchers are actively looking at it, made it feel a lot less like falling apart and a lot more like something worth understanding.
Learn more about Rose →Estrogen activates an enzyme called endothelial nitric oxide synthase (eNOS), which is responsible for producing nitric oxide in the lining of blood vessels. When estrogen levels fall during perimenopause and menopause, eNOS activity decreases, leading to reduced nitric oxide availability throughout the vascular system. This is not a subtle effect — studies using vascular tissue have shown measurable reductions in eNOS expression following estrogen withdrawal.
Nitric oxide acts as a natural vasodilator — it signals the smooth muscle cells surrounding blood vessels to relax, which keeps arteries open and blood flowing freely. When nitric oxide production drops, vessels become stiffer and more prone to constriction, which is one physiological explanation for why cardiovascular risk rises after menopause. This shift in vascular tone can also contribute to symptoms like cold extremities, headaches, and that harder-to-explain sense of circulatory sluggishness.
Inside endothelial cells, the enzyme eNOS converts L-arginine into nitric oxide and a byproduct called L-citrulline. Without adequate L-arginine available, nitric oxide production can be substrate-limited — meaning the machinery is present but the fuel is running low. Dietary sources of L-arginine include meat, fish, dairy, nuts, and legumes, and the body can also produce it endogenously, though this capacity may shift with age.
Researchers have observed something called the arginine paradox: even when plasma L-arginine levels appear sufficient, supplemental arginine can still increase nitric oxide output, suggesting that intracellular availability matters more than blood levels alone. One reason is that an enzyme called arginase competes with eNOS for L-arginine, and arginase activity tends to increase with age and inflammation — both of which are relevant in the menopause transition. This means the practical relationship between arginine intake and nitric oxide production is more nuanced than a simple input-output equation.
Nitric oxide plays a key role in genital arousal — it mediates smooth muscle relaxation in vaginal and clitoral tissue, enabling engorgement and lubrication in response to stimulation. The drop in both estrogen and nitric oxide during menopause contributes to the reduced arousal response and vaginal dryness that many women experience, effects that are often attributed solely to tissue atrophy. Research into nitric oxide-based mechanisms in genitourinary syndrome of menopause is ongoing and represents an underexplored area of the symptom picture.
Several small randomised trials have examined L-arginine supplementation in postmenopausal women and found modest reductions in systolic blood pressure and improvements in flow-mediated dilation — a standard measure of endothelial function. The effect sizes are not dramatic, and the studies are too small to be definitive, but the direction of evidence is consistent with the known physiology of the arginine-nitric oxide pathway. These findings are interesting enough to warrant larger trials, which have not yet happened at scale.
L-arginine supplementation is generally well tolerated at moderate doses, but it can interact with medications for blood pressure, erectile dysfunction drugs (which also work via nitric oxide pathways), and certain heart conditions — making professional guidance important before starting it. There is also evidence that in people with herpes simplex virus, high-dose arginine can promote viral replication, since the virus uses arginine for its own protein synthesis. The supplement landscape around arginine is heavily marketed toward athletic performance and sexual health, which means the evidence quality varies widely and cherry-picking is common.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.